Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route

Qiang Gao,Nanxi Chen,Baoyi Li,Menghang Zu,Ya Ma,Haiting Xu,Zhenhua Zhu,Rui L. Reis,Subhas C. Kundu,Bo Xiao

DOI: https://doi.org/10.1186/s12951-023-02286-3

IF: 10.2

2024-01-04

Journal of Nanobiotechnology

Abstract:The clinical application of conventional medications for hepatocellular carcinoma treatment has been severely restricted by their adverse effects and unsatisfactory therapeutic effectiveness. Inspired by the concept of 'medicine food homology', we extracted and purified natural exosome-like lipid nanoparticles (LNPs) from black mulberry ( Morus nigra L.) leaves. The obtained MLNPs possessed a desirable hydrodynamic particle size (162.1 nm), a uniform size distribution (polydispersity index = 0.025), and a negative surface charge (-26.6 mv). These natural LNPs were rich in glycolipids, functional proteins, and active small molecules (e.g., rutin and quercetin 3- O -glucoside). In vitro experiments revealed that MLNPs were preferentially internalized by liver tumor cell lines via galactose receptor-mediated endocytosis, increased intracellular oxidative stress, and triggered mitochondrial damage, resulting in suppressing the viability, migration, and invasion of these cells. Importantly, in vivo investigations suggested that oral MLNPs entered into the circulatory system mainly through the jejunum and colon, and they exhibited negligible adverse effects and superior anti-liver tumor outcomes through direct tumor killing and intestinal microbiota modulation. These findings collectively demonstrate the potential of MLNPs as a natural, safe, and robust nanomedicine for oral treatment of hepatocellular carcinoma.

biotechnology & applied microbiology,nanoscience & nanotechnology

What problem does this paper attempt to address?

This paper attempts to address the issues present in the treatment of Hepatocellular Carcinoma (HCC), particularly the significant side effects, unsatisfactory efficacy, and high recurrence rates associated with traditional treatment methods such as surgery and chemotherapy. In search of new treatment options, researchers extracted and purified a natural exosome-like lipid nanoparticle (Lipid Nanoparticles, LNPs) from black mulberry leaves, naming it MLNPs. These MLNPs exhibit good biocompatibility and targeting ability, can enter the bloodstream through oral administration, and are absorbed by liver tumor cells via galactose receptor-mediated endocytosis, thereby effectively inhibiting the proliferation, migration, and invasion of tumor cells. Additionally, MLNPs have shown significant anti-HCC effects in in vivo experiments and have a certain regulatory effect on the gut microbiota, demonstrating their potential as a novel oral nanomedicine for the treatment of Hepatocellular Carcinoma.